Malaysia's Pharmaniaga LifeScience Sdn Bhd (PLS) and Pharmaniaga Berhad have signed a Research Collaboration Agreement (RCA) with BioNet-Asia Co. Ltd of Thailand for the development of a 6-in-1 combination vaccine Hexavalent vaccine) for children’s healthcare. The combinational vaccine formulation will use BioNet formulation to develop Hexavalent vaccine in Malaysia by the end of 2023. Source: Biospectrum Asia 14/12/2022